DOCS (NYSE: DOCS) insider to sell 2,000 shares via option exercise

Rhea-AI Filing Summary

DOCS reported a proposed sale of 2,000 common shares via a stock option exercise on 03/03/2026. The filing lists the sale as through the issuer for cash.

It also discloses prior sales by KIRA WAMPLER, including 2,000 shares on 02/02/2026 for $74,660.00 and 2,000 shares on 01/02/2026 for $89,300.00.

Insights

Compliance Analyst

Form 144 lists a 2,000-share option-based sale and two recent 2,000-share dispositions by a reporting person.

The filing documents a proposed sale of 2,000 common shares on 03/03/2026 via a stock option exercise, identified as an issuer transaction settled for cash. This follows two recorded dispositions by KIRA WAMPLER in 01/2026 and 02/2026.

Compliance considerations are routine: confirm timing against the registration requirement and ensure proceeds reporting aligns with transactional receipts; subsequent filings may disclose settlement details and exact cash flows.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2000	52000.00	133811547	03/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/03/2026	Stock Option Exercise	ISSUER			2000	03/03/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KIRA WAMPLER 500 3rd Street Ste 510 San Francisco CA 94107	Common	02/02/2026	2000	74660.00
KIRA WAMPLER 500 3rd Street Ste 510 San Francisco CA 94107	Common	01/02/2026	2000	89300.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DOCS Form 144 disclose about the 03/03/2026 sale?

The filing discloses a proposed sale of 2,000 common shares on 03/03/2026 via a stock option exercise, designated as an issuer transaction settled for cash.

Who made recent sales reported in the DOCS filing?

KIRA WAMPLER is listed for prior sales: 2,000 shares on 02/02/2026 for $74,660.00 and 2,000 shares on 01/02/2026 for $89,300.00.

How many shares are proposed to be sold in the DOCS Form 144?

The document shows a proposed sale of 2,000 common shares on 03/03/2026 by means of a stock option exercise, settled for cash.

Does the filing state who receives the sale proceeds?

The Form 144 entry lists the transaction method as ISSUER and the sale type as Cash, indicating proceeds flow through the issuer transaction structure in the filing.

Are the past transactions by KIRA WAMPLER included in the Form 144?

Yes. The filing lists two past dispositions by KIRA WAMPLER: 2,000 shares on 02/02/2026 for $74,660.00 and 2,000 shares on 01/02/2026 for $89,300.00.